Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endoscopic removal of an unexpected colon foreign body.
Lian J, Xu A, Chen T, Chu Y, Tang Y, Ni Y, Xu M. Lian J, et al. Among authors: chu y. Endoscopy. 2025 Dec;57(S 01):E11-E12. doi: 10.1055/a-2500-3050. Epub 2025 Jan 14. Endoscopy. 2025. PMID: 39809291 No abstract available.
Efficacy of Traditional, Complementary, and Integrative Medicine in Pain and Psychological Distress Management for Pediatric Palliative Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Wu X, Lam CS, Chu YS, Deng W, Chan CWH, Au KY, Man SS, Li CK, Zhong C, Ho L, Cheung YT. Wu X, et al. Among authors: chu ys. J Pain Symptom Manage. 2025 Jan 10:S0885-3924(25)00007-7. doi: 10.1016/j.jpainsymman.2025.01.002. Online ahead of print. J Pain Symptom Manage. 2025. PMID: 39800142 Free article. Review.
Preliminary exploration of the association of CXCR6+T lymphocytes in T2D.
Zhong X, Fu B, Wang H, Zhang M, Jia S, Ren Z, Zhang Y, Wang W, Li T, Zhao J, Shi H, Chang Q, Ge F, Gong Y, Liu W, Chen S, Liao L, Zhuang Y, Tang J, Chu Y, Qiu F, Xu S, Li T. Zhong X, et al. Among authors: chu y. Int Immunopharmacol. 2025 Jan 10;147:113962. doi: 10.1016/j.intimp.2024.113962. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39798468
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial.
Msaouel P, Yu K, Yuan Y, Chen J, Yan X, Karki M, Duan F, Sheth RA, Rao P, Sircar K, Shah AY, Zurita AJ, Genovese G, Li M, Yeh CC, Dang M, Han G, Chu Y, Hallin M, Olson P, Yang R, Slavin D, Der-Torossian H, Chin CD, Tannir NM, Wang L, Gao J. Msaouel P, et al. Among authors: chu y. Nat Commun. 2025 Jan 10;16(1):578. doi: 10.1038/s41467-024-55642-8. Nat Commun. 2025. PMID: 39794332 Free PMC article. Clinical Trial.
6,213 results